Per Artursson

30.7k total citations · 8 hit papers
263 papers, 23.5k citations indexed

About

Per Artursson is a scholar working on Oncology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Per Artursson has authored 263 papers receiving a total of 23.5k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Oncology, 96 papers in Molecular Biology and 63 papers in Pharmaceutical Science. Recurrent topics in Per Artursson's work include Drug Transport and Resistance Mechanisms (97 papers), Advanced Drug Delivery Systems (41 papers) and Pharmacological Effects and Toxicity Studies (34 papers). Per Artursson is often cited by papers focused on Drug Transport and Resistance Mechanisms (97 papers), Advanced Drug Delivery Systems (41 papers) and Pharmacological Effects and Toxicity Studies (34 papers). Per Artursson collaborates with scholars based in Sweden, Germany and United States. Per Artursson's co-authors include Johan Karlsson, Kristina Luthman, Katrin Palm, Eva Ragnarsson, Tuulikki Lindmark, Christel A. S. Bergström, Ina Hubatsch, Patric Stenberg, Ulf Norinder and Kjell M. Vårum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Per Artursson

255 papers receiving 22.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

1991 1.5k citations Per Artursson et al. profile →
Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1

2001 1.2k citations Per Artursson, Kristina Luthman et al. Advanced Drug Delivery Reviews profile →
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers

2007 1.2k citations Per Artursson et al. profile →
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)

1994 636 citations Per Artursson, Tuulikki Lindmark et al. Pharmaceutical Research profile →
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

1997 596 citations Patric Stenberg, Kristina Luthman et al. Pharmaceutical Research profile →
Coexistence of passive and carrier-mediated processes in drug transport

2010 486 citations Per Artursson et al. profile →
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement

1997 478 citations Janet Hoogstraate, Per Artursson et al. Pharmaceutical Research profile →
Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues

2016 373 citations Patrik Lundquist, Per Artursson Advanced Drug Delivery Reviews profile →

Peers

Countries citing papers authored by Per Artursson

Since Specialization

Citations

This map shows the geographic impact of Per Artursson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Artursson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Artursson more than expected).

Fields of papers citing papers by Per Artursson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Artursson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Artursson. The network helps show where Per Artursson may publish in the future.

Co-authorship network of co-authors of Per Artursson

This figure shows the co-authorship network connecting the top 25 collaborators of Per Artursson. A scholar is included among the top collaborators of Per Artursson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Artursson. Per Artursson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Patient‐Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates 2025 ·Clinical and Translational Science ·(unknown), Basem A. Khalil, (unknown), (unknown), Leo Price, Natalia Dyubankova, Gerard J. P. van Westen, Herman van Vlijmen, Dorien J.M. Peters, Per Artursson	0
2	The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays 2025 ·Environmental Toxicology and Pharmacology ·Vesna Munić Kos, (unknown), Barira Islam, (unknown), (unknown), (unknown), Richard Svensson, (unknown), Elena Banti, Patrik Lundquist, (unknown), Iain Gardner, Ola Spjuth, Ian A. Cotgreave, Per Artursson	0
3	Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Patrik Lundquist, Eva Hagforsen, Michael Wagner, Mohammad Alimohammadi, Fábio Rabelo Melo, Gunnar Pejler, Per Artursson, Marie Carlson, Ola Rollman, Maria Lampinen	2
4	Expression of intestinal drug transporter proteins and metabolic enzymes in neonatal and pediatric patients 2024 ·International Journal of Pharmaceutics ·(unknown), (unknown), Joachim Brouwers, Marc Miserez, Ilse Hoffman, Maissa Rayyan, Per Artursson, Patrick Augustijns	2
5	Monitoring drug–target interactions through target engagement-mediated amplification on arrays and in situ 2022 ·Nucleic Acids Research ·(unknown), Lars Johansson, Eldar Abdurakhmanov, Nils Landegren, Liza Löf, Linda Arngården, Andries Blokzijl, Richard Svensson, Maria Hammond, Peter Lönn, Johannes Haybaeck, Masood Kamali‐Moghaddam, Annika Jenmalm Jensen, U. Helena Danielson, Per Artursson, Thomas Lundbäck, Ulf Landegren	3
6	The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patients 2022 ·International Journal of Pharmaceutics ·(unknown), (unknown), Joachim Brouwers, Marc Ferrante, Séverine Vermeire, Tim Vanuytsel, Per Artursson, Patrick Augustijns	11
7	Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer 2021 ·Therapeutic Advances in Medical Oncology ·(unknown), (unknown), (unknown), Magnus Ölander, Per Artursson, Bernd Clement, Dirk Bauerschlag	5
8	Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1 2017 ·Journal of Medicinal Chemistry ·Sabin Llona‐Minguez, Andreas Höglund, Elisée Wiita, Ingrid Almlöf, André Mateus, José Manuel Calderón‐Montaño, (unknown), Evert Homan, Olga Loseva, Paweł Baranczewski, Ann‐Sofie Jemth, Maria Häggblad, Ulf Märtens, Bo Lundgren, Per Artursson, Thomas Lundbäck, Annika Jenmalm Jensen, Ulrika Warpman Berglund, Martin Scobie, Thomas Helleday	18
9	Structure–metabolism-relationships in the microsomal clearance of piperazin-1-ylpyridazines 2017 ·MedChemComm ·Sabin Llona‐Minguez, (unknown), Paweł Baranczewski, Matthieu Desroses, Tobias Koolmeister, Per Artursson, Martin Scobie, Thomas Helleday	1
10	Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2) 2017 ·European Journal of Pharmaceutical Sciences ·Jenny M. Pedersen, (unknown), Christel A. S. Bergström, Johan Palm, Janet Hoogstraate, Per Artursson	29
11	Protein quantification of human hepatic drug transporters and metabolizing enzymes: an inter-laboratory and methodological comparison 2016 ·Drug Metabolism Reviews ·Christine Wegler, Fabienne Z. Gaugaz, Tommy B. Andersson, Jacek R. Wiśniewski, Diana Busch, Stefan Oswald, F. T. Weiss, Helen Hammer, Thomas Joos, Oliver Poetz, Heleen M. Wortelboer, Evita van de Steeg, Brahim Achour, Amin Rostami, Per Artursson	1
12	Early Identification of Clinically Relevant Drug Interactions With the Human Bile Salt Export Pump (BSEP/ABCB11) 2013 ·Toxicological Sciences ·Jenny M. Pedersen, Pär Matsson, Christel A. S. Bergström, Janet Hoogstraate, Agneta Norén, Edward L. LeCluyse, Per Artursson	114
13	Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs 2013 ·European Journal of Pharmaceutical Sciences ·Christel A. S. Bergström, René Holm, (unknown), Sara Andersson, Per Artursson, Stefania Beato, Anders Borde, Karl Box, Marcus E. Brewster, Jennifer Dressman, (unknown), Gavin Halbert, Edmund Kostewicz, Mark McAllister, Uwe Muenster, (unknown), Robert Taylor, Anette Müllertz	206
14	Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers 2004 ·Gene Therapy ·Magnus Köping‐Höggård, (unknown), Mohamed Issa, Signe Danielsen, Bjørn E. Christensen, Bjørn T. Stokke, Per Artursson	294
15	A new approach to chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers 2003 ·Gene Therapy ·Magnus Köping‐Höggård, (unknown), Mohamed Issa, Signe Danielsen, Bjørn E. Christensen, Bjørn T. Stokke, Per Artursson	2
16	An Improved Cell Culture Model Based on 2/4/A1 Cell Monolayers for Studies of Intestinal Drug Transport: Characterization of Transport Routes 2003 ·Pharmaceutical Research ·Staffan Tavelin, Jan Taipalensuu, Finn Hallböök, Kati‐Sisko Vellonen, Vanessa Moore, Per Artursson	40
17	A Novel Approach for Prediction of Intestinal Absorption of Drugs in Humans based on Hydrogen Bond Descriptors and Structural Similarity 2001 ·Quantitative Structure-Activity Relationships ·Oleg A. Raevsky, K.‐J. Schaper, Per Artursson, James W. McFarland	19
18	Virtual screening of intestinal drug permeability 2000 ·Journal of Controlled Release ·Patric Stenberg, Kristina Luthman, Per Artursson	70
19	Regulation of immediate and long term effects of the absorption enhancer sodium caprate in human intestinal epithelial (Caco-2) cells 1996 ·Yukitaka Kimura, Tuulikki Lindmark, Per Artursson	3
20	Cell cultures to assess drug transport and metabolism - Preface 1996 ·Advanced Drug Delivery Reviews ·(unknown), Per Artursson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact